Neurology News

In this edition, risk factors linked to PD, digital brain health platform offers dementia risk assessment, Klotho protein levels linked to Alzheimer's and more.

Lecanemab reduced amyloid markers and slowed cognitive decline in patients with early Alzheimer’s disease, although not without risk for adverse events, according to new data published in The New England Journal of Medicine.

Although melatonin is not recommended by the American Academy of Sleep Medicine as an insomnia treatment, about 70% of primary care physicians believe it is, a survey from The Alliance For Sleep found.

Biotechnology company Cajal Neuroscience announced its launch with $96 million Series A financing with plans to combine human genetics, functional genomics and advanced microscopy to expand drug discovery for neurodegenerative diseases.

Nearly 90% of patients with relapsing-remitting MS in a multicenter study in Germany preferred subcutaneous administration of Tysabri rather than IV, citing shorter duration of delivery and convenience, per a presentation at ECTRIMS 2022.

Preclinical biotech company Eikonoklastes Therapeutics and gene therapy manufacturer Forge Biologics announced a partnership that will advance Eikonoklastes’ ET-101 gene therapy into clinical trials for patients with ALS.

Samsung Electronics health care subsidiary NeuroLogica Corp. announced it has received 510(k) clearance from the FDA for its BodyTom 64, a mobile head-to-toe CT scanner that can be used for a variety of health care needs.

Posterior cervical foraminotomy was noninferior to anterior cervical discectomy with fusion in success rate and arm pain at 1 year in patients with cervical radiculopathy, researchers reported in JAMA Neurology.

I’ve been a primary care provider now for 37 years, but I still remember my early days of residency well.

The Feinstein Institutes for Medical Research has been awarded a $3.6 million grant, to be distributed over 5 years, from the New York State Department of Health for the study of spinal cord simulation and novel brain implant technology.